Search Results 171-180 of 2202 for ⚓양방수익형 매충50%/녹이기성공80%죽장/녹이기실패100%죽장 [양방작업.COM][텔@JP1004] 양방수익증가방식 올자판기⚓

  1. A Study to Evaluate the Impact on NASH with Fibrosis of Obeticholic Acid Treatment - Mayo Clinic

    The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver- ...

  2. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

    The aim of this study is to assess the safety and preliminary efficacy of treatment with EXE-346, a live biotherapeutic, which may reduce bowel movement ...

  3. A Study to Understand Clinical Reasoning Growth in Occupational and Physical Therapy Students’ when Participating in a Traditional or Collaborative Model in the Clinic - Mayo Clinic

    3. Understand students' preferred learning styles and teaching strategies during occupational or physical therapy internship. Participation eligibility.

  4. Safety of MT-401-OTS in Patients with Relapsed AML or MDS - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Serum Levels of Patients on Low Dose Naltrexone - Mayo Clinic

    About this study. The purpose of this study is to understand if low dose naltrexone can be measured in the blood, when using as a Long COVID treatment.

  6. Ixabepilone and Temsirolimus in Treating Patients with Solid Tumors that are Metastatic or Cannot ce Removed by Surgery - Mayo Clinic

    Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving ixabepilone together with temsirolimus may kill ...

  7. Long-Term Safety of PF-00547659 in Ulcerative Colitis - Mayo Clinic

    Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to evaluate ...

  8. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  9. cGMP Dolcanatide Responders - Clinical Trials

    The purpose of this study is to explore the level of similarity in pharmacodynamic responses to GUCY2C agonists in organoids prepared from rectal biopsies from ...

  10. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    About this study. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other ...